PCDHGB9P

Across TCGA pan-cancer cohorts, PCDHGB9P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated PCDHGB9P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher PCDHGB9P RNA is associated with better overall survival. In most high-consensus cancer types, elevated PCDHGB9P expression acts as an unfavorable survival marker, although some lineages such as UCS and COAD show a favorable association.

UCS, HNSC, and THCA are the cancer types where PCDHGB9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	III,IV	0.833	0.393	.006	66	view →
HNSC	DFS	Median	II,III,IV	0.552	0.747	<.001	53	view →
THCA	OS	Quartile	II,III,IV	0.712	1.000	.002	40	view →
UVM	DFS	Median	All	0.425	0.759	<.001	34	view →
COAD	OS	Median	II,III,IV	0.753	0.441	.002	28	view →
KIRC	DFS	Median	II,III,IV	0.620	0.759	.001	23	view →
KIRP	DFS	Tertile	All	0.478	0.664	.003	22	view →
MESO	DFS	Tertile	II,III,IV	0.337	0.686	.012	21	view →
LGG	DFS	Quartile	All	0.376	0.530	.005	21	view →
BRCA	OS	Quartile	II,III,IV	0.874	0.937	.019	21	view →
BLCA	DFS	Median	All	0.189	0.476	.012	16	view →
ACC	DFS	Quartile	IV	0.116	0.710	.006	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

PCDHGB9P–UCS (OS)

Open the UCS breakdown →